• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

COVID-19 Impact on Subcutaneous Injection Market, Global Research Reports 2020-2021

report cover
  • 20 May 2020
  • Pharmaceuticals
  • 95 Pages
  • Report Code: 24LS-2833
  • Formate :   
Download FREE Report Sample Download PDF File

COVID 19 Impact Subcutaneous Injecti Market Reports -MARKET ADVISORY SERVICES

This report covers market size and forecasts of Subcutaneous Injection, including the following market information:
Global Subcutaneous Injection Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Subcutaneous Injection Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Subcutaneous Injection Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Subcutaneous Injection Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)

Key market players
Major competitors identified in this market include Becton Dickinson, Daiichi Sankyo, Sanofi, Roche, GSK, Eli Lilly, Asahi Kasei Pharma, Takeda Pharmaceutical, Antares Pharma, Inc., Eisai Co.?Ltd, Chugai Pharmaceutical, Endo International, PenJet Corporation, Aspen Medical Group, etc.

Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)

Based on the Type:
Subcutaneous Injection Equipment
Subcutaneous Injection Drug
Others

Based on the Application:
Hospital
Clinic
Laboratory
Others
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Subcutaneous Injection Industry
1.7 COVID-19 Impact: Subcutaneous Injection Market Trends

2 Global Subcutaneous Injection Quarterly Market Size Analysis
2.1 Subcutaneous Injection Business Impact Assessment - COVID-19
2.1.1 Global Subcutaneous Injection Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Subcutaneous Injection Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges

3 Quarterly Competitive Assessment, 2020
3.1 By Players, Global Subcutaneous Injection Quarterly Market Size, 2019 VS 2020
3.2 By Players, Subcutaneous Injection Headquarters and Area Served
3.3 Date of Key Players Enter into Subcutaneous Injection Market
3.4 Key Players Subcutaneous Injection Product Offered
3.5 Mergers & Acquisitions, Expansion Plans

4 Impact of Covid-19 on Subcutaneous Injection Segments, By Type
4.1 Introduction
1.4.1 Subcutaneous Injection Equipment
1.4.2 Subcutaneous Injection Drug
1.4.3 Others
4.2 By Type, Global Subcutaneous Injection Market Size, 2019-2021

5 Impact of Covid-19 on Subcutaneous Injection Segments, By Application
5.1 Overview
5.5.1 Hospital
5.5.2 Clinic
5.5.3 Laboratory
5.5.4 Others
5.2 By Application, Global Subcutaneous Injection Market Size, 2019-2021
5.2.1 By Application, Global Subcutaneous Injection Market Size by Application, 2019-2021

6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa

7 Company Profiles
7.1 Becton Dickinson
7.1.1 Becton Dickinson Business Overview
7.1.2 Becton Dickinson Subcutaneous Injection Quarterly Revenue, 2020
7.1.3 Becton Dickinson Subcutaneous Injection Product Introduction
7.1.4 Becton Dickinson Response to COVID-19 and Related Developments
7.2 Daiichi Sankyo
7.2.1 Daiichi Sankyo Business Overview
7.2.2 Daiichi Sankyo Subcutaneous Injection Quarterly Revenue, 2020
7.2.3 Daiichi Sankyo Subcutaneous Injection Product Introduction
7.2.4 Daiichi Sankyo Response to COVID-19 and Related Developments
7.3 Sanofi
7.3.1 Sanofi Business Overview
7.3.2 Sanofi Subcutaneous Injection Quarterly Revenue, 2020
7.3.3 Sanofi Subcutaneous Injection Product Introduction
7.3.4 Sanofi Response to COVID-19 and Related Developments
7.4 Roche
7.4.1 Roche Business Overview
7.4.2 Roche Subcutaneous Injection Quarterly Revenue, 2020
7.4.3 Roche Subcutaneous Injection Product Introduction
7.4.4 Roche Response to COVID-19 and Related Developments
7.5 GSK
7.5.1 GSK Business Overview
7.5.2 GSK Subcutaneous Injection Quarterly Revenue, 2020
7.5.3 GSK Subcutaneous Injection Product Introduction
7.5.4 GSK Response to COVID-19 and Related Developments
7.6 Eli Lilly
7.6.1 Eli Lilly Business Overview
7.6.2 Eli Lilly Subcutaneous Injection Quarterly Revenue, 2020
7.6.3 Eli Lilly Subcutaneous Injection Product Introduction
7.6.4 Eli Lilly Response to COVID-19 and Related Developments
7.7 Asahi Kasei Pharma
7.7.1 Asahi Kasei Pharma Business Overview
7.7.2 Asahi Kasei Pharma Subcutaneous Injection Quarterly Revenue, 2020
7.7.3 Asahi Kasei Pharma Subcutaneous Injection Product Introduction
7.7.4 Asahi Kasei Pharma Response to COVID-19 and Related Developments
7.8 Takeda Pharmaceutical
7.8.1 Takeda Pharmaceutical Business Overview
7.8.2 Takeda Pharmaceutical Subcutaneous Injection Quarterly Revenue, 2020
7.8.3 Takeda Pharmaceutical Subcutaneous Injection Product Introduction
7.8.4 Takeda Pharmaceutical Response to COVID-19 and Related Developments
7.9 Antares Pharma, Inc.
7.9.1 Antares Pharma, Inc. Business Overview
7.9.2 Antares Pharma, Inc. Subcutaneous Injection Quarterly Revenue, 2020
7.9.3 Antares Pharma, Inc. Subcutaneous Injection Product Introduction
7.9.4 Antares Pharma, Inc. Response to COVID-19 and Related Developments
7.10 Eisai Co.?Ltd
7.10.1 Eisai Co.?Ltd Business Overview
7.10.2 Eisai Co.?Ltd Subcutaneous Injection Quarterly Revenue, 2020
7.10.3 Eisai Co.?Ltd Subcutaneous Injection Product Introduction
7.10.4 Eisai Co.?Ltd Response to COVID-19 and Related Developments
7.11 Chugai Pharmaceutical
7.11.1 Chugai Pharmaceutical Business Overview
7.11.2 Chugai Pharmaceutical Subcutaneous Injection Quarterly Revenue, 2020
7.11.3 Chugai Pharmaceutical Subcutaneous Injection Product Introduction
7.11.4 Chugai Pharmaceutical Response to COVID-19 and Related Developments
7.12 Endo International
7.12.1 Endo International Business Overview
7.12.2 Endo International Subcutaneous Injection Quarterly Revenue, 2020
7.12.3 Endo International Subcutaneous Injection Product Introduction
7.12.4 Endo International Response to COVID-19 and Related Developments
7.13 PenJet Corporation
7.13.1 PenJet Corporation Business Overview
7.13.2 PenJet Corporation Subcutaneous Injection Quarterly Revenue, 2020
7.13.3 PenJet Corporation Subcutaneous Injection Product Introduction
7.13.4 PenJet Corporation Response to COVID-19 and Related Developments
7.14 Aspen Medical Group
7.14.1 Aspen Medical Group Business Overview
7.14.2 Aspen Medical Group Subcutaneous Injection Quarterly Revenue, 2020
7.14.3 Aspen Medical Group Subcutaneous Injection Product Introduction
7.14.4 Aspen Medical Group Response to COVID-19 and Related Developments

8 Key Findings

9 Appendix
9.1 About US
9.2 Disclaimer
List of Tables

Table 1. Overview of the World Economic Outlook Projections

Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)

Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 7. Covid-19 Impact: Global Major Government Policy

Table 8. The Covid-19 Impact on Subcutaneous Injection Assessment

Table 9. COVID-19 Impact: Subcutaneous Injection Market Trends

Table 10. COVID-19 Impact Global Subcutaneous Injection Market Size

Table 11. Global Subcutaneous Injection Quarterly Market Size, 2020 (US$ Million)

Table 12. Global Subcutaneous Injection Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)

Table 13. Global Subcutaneous Injection Market Growth Drivers

Table 14. Global Subcutaneous Injection Market Restraints

Table 15. Global Subcutaneous Injection Market Opportunities

Table 16. Global Subcutaneous Injection Market Challenges

Table 17. By Players, Subcutaneous Injection Quarterly Revenue, 2019 VS 2020 (US$ Million)

Table 18. Key Players, Subcutaneous Injection Revenue Market Share, 2019 VS 2020 (%)

Table 19. Key Subcutaneous Injection Players Headquarters and Area Served

Table 20. Date of Key Players Enter into Subcutaneous Injection Market

Table 21. Key Players Subcutaneous Injection Product Type

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. By Players, Global Subcutaneous Injection Market Size 2019-2021, (US$ Million)

Table 24. Global Subcutaneous Injection Market Size by Application: 2019-2021 (US$ Million)

Table 25. Global Subcutaneous Injection Market Size by Region, 2019-2021 (US$ Million)

Table 26. By Country, North America Subcutaneous Injection Market Size, 2019-2021 (US$ Million)

Table 27. By Type, US Subcutaneous Injection Market Size, 2019-2021 (US$ Million)

Table 28. By Application, US Subcutaneous Injection Market Size, 2019-2021 (US$ Million)

Table 29. By Type, Canada Subcutaneous Injection Market Size, 2019-2021 (US$ Million)

Table 30. By Application, Canada Subcutaneous Injection Market Size, 2019-2021 (US$ Million)

Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)

Table 32. By Country, Europe Subcutaneous Injection Market Size, 2019-2021 (US$ Million)

Table 33. By Type, Germany Subcutaneous Injection Market Size, 2019-2021 (US$ Million)

Table 34. By Application, Germany Subcutaneous Injection Market Size, 2019-2021 (US$ Million)

Table 35. By Type, France Subcutaneous Injection Market Size, 2019-2021 (US$ Million)

Table 36. By Application, France Subcutaneous Injection Market Size, 2019-2021 (US$ Million)

Table 37. By Type, UK Subcutaneous Injection Market Size, 2019-2021 (US$ Million)

Table 38. By Application, UK Subcutaneous Injection Market Size, 2019-2021 (US$ Million)

Table 39. By Type, Italy Subcutaneous Injection Market Size, 2019-2021 (US$ Million)

Table 40. By Application, Italy Subcutaneous Injection Market Size, 2019-2021 (US$ Million)

Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)

Table 42. By Region, Asia-Pacific Subcutaneous Injection Market Size, 2019-2021 (US$ Million)

Table 43. By Type, China Subcutaneous Injection Market Size, 2019-2021 (US$ Million)

Table 44. By Application, China Subcutaneous Injection Market Size, 2019-2021 (US$ Million)

Table 45. By Type, Japan Subcutaneous Injection Market Size, 2019-2021 (US$ Million)

Table 46. By Application, Japan Subcutaneous Injection Market Size, 2019-2021 (US$ Million)

Table 47. By Type, South Korea Subcutaneous Injection Market Size, 2019-2021 (US$ Million)

Table 48. By Application, South Korea Subcutaneous Injection Market Size, 2019-2021 (US$ Million)

Table 49. By Type, India Subcutaneous Injection Market Size, 2019-2021 (US$ Million)

Table 50. By Application, India Subcutaneous Injection Market Size, 2019-2021 (US$ Million)

Table 51. By Type, ASEAN Subcutaneous Injection Market Size, 2019-2021 (US$ Million)

Table 52. By Application, ASEAN Subcutaneous Injection Market Size, 2019-2021 (US$ Million)

Table 53. By Type, Latin America Subcutaneous Injection Market Size, 2019-2021 (US$ Million)

Table 54. By Application, Latin America Subcutaneous Injection Market Size, 2019-2021 (US$ Million)

Table 55. By Type, Middle East and Africa Subcutaneous Injection Market Size, 2019-2021 (US$ Million)

Table 56. By Application, Middle East and Africa Subcutaneous Injection Market Size, 2019-2021 (US$ Million)

Table 57. Becton Dickinson Business Overview

Table 58. Becton Dickinson Subcutaneous Injection Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020

Table 59. Becton Dickinson Subcutaneous Injection Product

Table 60. Becton Dickinson Response to COVID-19 and Related Developments

Table 61. Daiichi Sankyo Business Overview

Table 62. Daiichi Sankyo Subcutaneous Injection Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020

Table 63. Daiichi Sankyo Subcutaneous Injection Product

Table 64. Daiichi Sankyo Response to COVID-19 and Related Developments

Table 65. Sanofi Business Overview

Table 66. Sanofi Subcutaneous Injection Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020

Table 67. Sanofi Subcutaneous Injection Product

Table 68. Sanofi Response to COVID-19 and Related Developments

Table 69. Roche Business Overview

Table 70. Roche Subcutaneous Injection Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020

Table 71. Roche Subcutaneous Injection Product

Table 72. Roche Response to COVID-19 and Related Developments

Table 73. GSK Business Overview

Table 74. GSK Subcutaneous Injection Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020

Table 75. GSK Subcutaneous Injection Product

Table 76. GSK Response to COVID-19 and Related Developments

Table 77. Eli Lilly Business Overview

Table 78. Eli Lilly Subcutaneous Injection Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020

Table 79. Eli Lilly Subcutaneous Injection Product

Table 80. Eli Lilly Response to COVID-19 and Related Developments

Table 81. Asahi Kasei Pharma Business Overview

Table 82. Asahi Kasei Pharma Subcutaneous Injection Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020

Table 83. Asahi Kasei Pharma Subcutaneous Injection Product

Table 84. Asahi Kasei Pharma Response to COVID-19 and Related Developments

Table 85. Takeda Pharmaceutical Business Overview

Table 86. Takeda Pharmaceutical Subcutaneous Injection Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020

Table 87. Takeda Pharmaceutical Subcutaneous Injection Product

Table 88. Takeda Pharmaceutical Response to COVID-19 and Related Developments

Table 89. Antares Pharma, Inc. Business Overview

Table 90. Antares Pharma, Inc. Subcutaneous Injection Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020

Table 91. Antares Pharma, Inc. Subcutaneous Injection Product

Table 92. Antares Pharma, Inc. Response to COVID-19 and Related Developments

Table 93. Eisai Co.?Ltd Business Overview

Table 94. Eisai Co.?Ltd Subcutaneous Injection Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020

Table 95. Eisai Co.?Ltd Subcutaneous Injection Product

Table 96. Eisai Co.?Ltd Response to COVID-19 and Related Developments

Table 97. Chugai Pharmaceutical Business Overview

Table 98. Chugai Pharmaceutical Subcutaneous Injection Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020

Table 99. Chugai Pharmaceutical Subcutaneous Injection Product

Table 100. Chugai Pharmaceutical Response to COVID-19 and Related Developments

Table 101. Endo International Business Overview

Table 102. Endo International Subcutaneous Injection Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020

Table 103. Endo International Subcutaneous Injection Product

Table 104. Endo International Response to COVID-19 and Related Developments

Table 105. PenJet Corporation Business Overview

Table 106. PenJet Corporation Subcutaneous Injection Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020

Table 107. PenJet Corporation Subcutaneous Injection Product

Table 108. PenJet Corporation Response to COVID-19 and Related Developments

Table 109. Aspen Medical Group Business Overview

Table 110. Aspen Medical Group Subcutaneous Injection Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020

Table 111. Aspen Medical Group Subcutaneous Injection Product

Table 112. Aspen Medical Group Response to COVID-19 and Related Developments

List of Figures

Figure 1. Subcutaneous Injection Product Picture

Figure 2. Subcutaneous Injection Market Segmentation

Figure 3. Research Objectives

Figure 4. Research Process

Figure 5. Data Triangulation

Figure 6. Research Approach

Figure 7. Commodity Prices-Metals Price Indices

Figure 8. Commodity Prices- Precious Metal Price Indices

Figure 9. Commodity Prices- Agricultural Raw Material Price Indices

Figure 10. Commodity Prices- Food and Beverage Price Indices

Figure 11. Commodity Prices- Fertilizer Price Indices

Figure 12. Commodity Prices- Energy Price Indices

Figure 13. G20+: Economic Policy Responses to COVID-19

Figure 14. Global Subcutaneous Injection Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)

Figure 15. Global Subcutaneous Injection Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)

Figure 16. Global Subcutaneous Injection Market Size, Quarterly Growth, 2020-2021 (%)

Figure 17. Global Subcutaneous Injection Market Size, Market Share by Type, 2019 VS 2020 (%)

Figure 18. Global Subcutaneous Injection Market Size, Market Share by Application, 2019 VS 2020 (%)

Figure 19. Global Subcutaneous Injection Market Size Market Share by Region, 2019 VS 2020 (%)

Figure 20. United States Composite PMI and GDP

Figure 21. Eurozone Composite PMI and GDP

Figure 22. Eurozone Core v. Periphery PMI Output Indices

Figure 23. Core v. Periphery PMI Employment Indices

Figure 24. UK Composite PMI and GDP

Figure 25. Caixin China Composite Output Index

Figure 26. Caixin China General Services Business Activity Index

Figure 27. Japan Composite Output Index

Figure 28. South Korea Manufacturing PMI

Figure 29. India Composite Output Index

Figure 30. ASEAN Manufacturing PMI

Figure 31. By Region, Asia-Pacific Subcutaneous Injection Market Size Market Share, 2019-2021

Becton Dickinson

Daiichi Sankyo

Sanofi

Roche

GSK

Eli Lilly

Asahi Kasei Pharma

Takeda Pharmaceutical

Antares Pharma, Inc.

Eisai Co.?Ltd

Chugai Pharmaceutical

Endo International

PenJet Corporation

Aspen Medical Group

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $2633

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase